Cancer Biochemistry PDF
Document Details
Uploaded by HandsDownNovaculite3059
CESPU
Tags
Summary
This document provides an overview of cancer biochemistry, focusing on target tumor metabolism, new drug strategies, and multidrug resistance. It also briefly touches on epidemiology and the causes of cancer.
Full Transcript
Target tumor metabolism: Achilles’ heel Lower doses to minimize side effects **New Drug Strategies**...
Target tumor metabolism: Achilles’ heel Lower doses to minimize side effects **New Drug Strategies** Enhance specificity for tumor cells Efflux Pumps: P-glycoprotein expels drugs Mechanisms Microenvironmental Factors: Tumor pH and hypoxia reduce drug efficacy **Multidrug Resistance (MDR)** Common in domestic pets (dogs, cats) Pre-treatment with metabolic inhibitors **Epidemiology** Solutions Influenced by lifestyle factors, genetic predispositions, and differing exposures to environmental carcinogens Polypharmacological therapy Genetic heritage Develop therapies that specifically target tumor vulnerabilities (e.g., metabolism, angiogenesis) **Goals** **Multifactorial Disease** Lifestyle: diet, habits Reduce side effects and resistance through multimodal approaches Environmental factors: occupational, social, **Treatment** **Causes of Cancer** cultural Antiglycolytic agents: 3-BP, 2-DG, DCA **Emerging Approaches** Internal: immune response, genetic predispositions Combination therapies to counter resistance **Internal vs External Causes** External: 80–90% related to environment Screening: Detect early-stage cancers (e.g., PSA for prostate cancer) Fatty foods: red meats, fried foods Diagnosis and Prognosis: Confirm cancer types and predict outcomes. Nitrites: processed meats (pickles, sausages) **Dietary** Treatment Monitoring: Track response and Smoked/barbecued foods: tar from coal smoke detect relapses High-temperature cooking α-Fetoprotein: Elevated in liver cancer. Solar radiation → skin cancers Carcinoembryonic Antigen (CEA): Monitors colon and pancreatic cancer Examples: **Tumor Markers** Chemicals → carcinogens (benzaldehyde) PSA: Prostate-specific antigen for prostate cancer **Risk Factors** **Environmental** Viruses: HPV → cervical cancer Sustained Proliferative Signaling: Tumors continuously signal cells to divide Bacteria: H. pylori → gastric cancer Evading Apoptosis: Cancer cells resist programmed cell death Radiation: UV and ionizing radiation cause direct DNA damage, leading to mutations Angiogenesis: They induce blood vessel formation. Key Hallmarks (Hanahan and Weinberg, 2011): **Hormonal** Sterilization reduces breast tumor risk in pets Metabolic Reprogramming: Tumors increase glucose uptake and modify nutrient usage to fuel rapid growth Certain dog breeds have higher risks: Golden **Genetic Predispositions** Retrievers, Boxers Tumors prefer glycolysis for ATP production, producing large amounts of lactate, even in aerobic conditions Metabolic Reprogramming: Tumors prioritize glycolysis (Warburg effect), Increased glycolysis meets anabolic needs for rapid proliferation. even in oxygen-rich conditions Cancer Biochemistry Benign: Benign tumors are non-invasive and localized, posing minimal risk unless their growth interferes with vital functions Mind Map **Benign vs Malignant Tumors** Malignant: invasive, metastatic Weight loss, muscle wasting, anemia **Symptoms** Loss of cell adhesion (E-cadherin): They Insulin resistance, high cortisol, lipolysis, evade neighboring tissues proteolysis Invasive capability: They cross barriers, aided **Malignancy Mechanisms** Tumors outcompete normal tissues for glucose by enzymes like collagenase and nutrients **Cancer Development** Metastasis: They spread through blood and Increased proteolysis and lipolysis lead to lymphatic systems to colonize distant organs muscle wasting and fat loss **Mechanisms** **Cachexia in Cancer** Initiation: Genetic mutations occur due to Elevated cortisol and pro-inflammatory carcinogens (DNA damage) cytokines drive metabolic disruption Promotion: Mutated cells proliferate under "oncopromoters," **Stages of Carcinogenesis** Low-carbohydrate diets or metabolic modulators may a process that may halt if exposure ceases help reduce tumor resource access Progression: Uncontrolled cell division becomes irreversible, solidifying cancer and metastasis High glycolytic rates result in excessive lactate production. Checkpoint Regulation: It halts the cell cycle at the G1/S transition if Reduced mitochondrial activity exacerbates DNA damage is detected, allowing repair mechanisms to act lactate buildup Lactic Acidosis in Cancer **p53 – Guardian of the Genome** Apoptosis Induction: If DNA damage is irreparable, p53 initiates programmed Implications include systemic acidosis and cell death (apoptosis) to prevent the survival of defective cells nutrient deficiencies **Genetics in Cancer** Proto-oncogenes: Normal genes regulating growth and division. When Example: RAS, which controls cell signaling, mutated, they become oncogenes, driving malignancy often mutates to promote uncontrolled division HIF1 Activation: Stimulates glycolytic enzymes **Oncogenes vs Tumor Suppressor Genes** and VEGF expression for angiogenesis Tumor Suppressor Genes: Prevent tumor formation by regulating the cell cycle TP53 (p53), RB1 (retinoblastoma protein) Effects of Hypoxia: or apoptosis. Mutations lead to a loss of this protective function Metabolic Adaptation: Enhances tumor survival in oxygen-poor environments. **Hypoxia and Angiogenesis** Types of Mutations: Include point mutations, deletions, and Tumors release VEGF, binding to endothelial cell chromosomal translocations. These can activate oncogenes receptors. or disable tumor suppressor genes Angiogenesis Process: Mechanisms of Mutation: Endothelial cells proliferate and migrate toward Early mutations in APC (a tumor suppressor gene) the tumor, forming new blood vessels Sequence of Events: For instance, in colon cancer: Later mutations in KRAS (oncogene) and p53, resulting in progression to malignancy Plasma membrane fluidity increases, enabling migration. **Mutations and Cancer** Structural Changes: Structural Changes: Cancer cells have increased plasma membrane fluidity and less organized Loss of cytoskeletal organization gives cells a rounded shape. cytoskeletons, making them more invasive Cancer cells proliferate uncontrollably and evade apoptosis. Functional Changes: They lose specialized Functional Changes: Tumor Cell Changes Consequences of Mutations: functions and become "immortal," dividing They induce angiogenesis (new blood vessel formation) to indefinitely sustain growth Metabolic Changes: Tumor cells consume more Increased glucose uptake and metabolic activity energy, altering host metabolism. Metabolic Changes: **Metabolism in Tumor Cells** Metabolic shifts benefit tumor survival but strain the host Tumors compress nearby tissues, impairing their Local Effects: function Biochemical markers, such as elevated liver Tumor Characteristics enzymes or LDH, indicate systemic changes Systemic Effects: Tumors often hijack nutrients, disrupting normal metabolism